MYC and Cirrhosis: Novel data suggest that deregulation of c-MYC function is not only associated with HCC development, but also with CLD (e.g., ALD, viral hepatitis, liver fibrosis/cirrhosis, for hepatoblastoma and cholangiocarcinoma, etc.)[8].